Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

To
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

Status Brand name Company Name Strength(s) Date Updated View Report
Resolved NALOXONE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED 0.4MG 2025-08-18 210664
Resolved TAMSULOSIN CR PRO DOC LIMITEE 0.4MG 2025-05-21 215019
Resolved NALOXONE HCL INJECTION - 0.4MG/ML USP SANDOZ CANADA INCORPORATED 0.4MG 2017-04-12 3820
Resolved SCOPOLAMINE HYDROBROMIDE INJECTION OMEGA LABORATORIES LIMITED 0.4MG 2019-03-23 66030
Avoided shortage NALOXONE HCL INJECTION - 0.4MG/ML USP SANDOZ CANADA INCORPORATED 0.4MG 2017-06-26 3823
Resolved APO-TAMSULOSIN CR APOTEX INC 0.4MG 2025-05-21 200177
Resolved S.O.S. NALOXONE HYDROCHLORIDE INJECTION SANDOZ CANADA INCORPORATED 0.4MG 2017-06-26 3826
Resolved SCOPOLAMINE HYDROBROMIDE INJECTION OMEGA LABORATORIES LIMITED 0.4MG 2020-06-09 110834
Discontinued APO-NITROGLYCERIN APOTEX INC 0.4MG 2018-02-26 40947
Resolved TEVA-TAMSULOSIN CR TEVA CANADA LIMITED 0.4MG 2023-07-05 195827
Resolved MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC 0.4MG 2022-11-22 172533
Resolved NITROLINGUAL PUMPSPRAY SANOFI-AVENTIS CANADA INC 0.4MG 2024-05-03 186615
Resolved NITROLINGUAL PUMPSPRAY SANOFI-AVENTIS CANADA INC 0.4MG 2024-06-15 186618
Resolved TEVA-TAMSULOSIN CR TEVA CANADA LIMITED 0.4MG 2025-05-21 209148
Resolved SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED 0.4MG 2023-05-03 188668
Resolved SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED 0.4MG 2021-08-16 143869
Resolved APO-TAMSULOSIN CR APOTEX INC 0.4MG 2022-10-14 167421
Resolved ATROPINE INJECTION BP HIKMA CANADA LIMITED 0.4MG 2024-04-16 210686
Resolved MYLAN-FINGOLIMOD MYLAN PHARMACEUTICALS ULC 0.5 mg 2020-03-13 101762
Resolved M-M-R II MERCK CANADA INC 0.5 mL dose after reconstitution Measles: ≥1000 CCID50 Mumps: ≥5000 CCID50 Rubella: ≥1000 CCID50 2017-05-15 4420

Showing 1821 to 1840 of 27797